Analyst Downgrades – Aviragen Therapeutics (NASDAQ:AVIR) Stock Gets ... - Market Exclusive

Highland Mirror
Analyst Downgrades – Aviragen Therapeutics (NASDAQ:AVIR) Stock Gets ...
Market Exclusive
Today, Aviragen Therapeutics (NASDAQ:AVIR) stock was downgraded by Ladenburg Thalmann Financial Services from Buy to Neutral. There are 1 hold rating, 2 buy ratings on the stock. The current consensus rating on Aviragen Therapeutics ...
Aviragen Therapeutics (AVIR) is Downgraded by Ladenburg Thalmann to ...Highland Mirror
Aviragen Therapeutics, Inc. (AVIR) Downgraded by Ladenburg